India's Covaxin Shot 78% Effective Against Coronavirus, Say Developers

India's Covaxin Shot 78% Effective Against Coronavirus, Say Developers

April 22, 2021, 7:20 a.m.

India's only domestically developed COVID-19 vaccine, Covaxin, has been found to be 78% effective in a second analysis of clinical trials done around the country, its makers said here on Wednesday.

“I am very pleased to state that Covaxin ... has shown the efficacy of 78% in the second interim analysis,” said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech.

The first analysis released in March had shown an efficacy rate of 81%.

More on Health

The Latest

Latest Magazine

VOL. 15, No. 21, June.24,2022 (Ashad 10. 2079) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 20, June.03,2022 (Jestha 20. 2079) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 19, May.20,2022 (Jestha 06. 2079) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 18, May.06,2022 (Baishakh 23. 2079) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75